1 of 2
Click on image to open expanded view
Item No.
51158
Entyce 30 mg/ml Capromorelin Oral Solution for Dogs Description
Entyce 30 mg/ml Capromorelin Oral Solution is indicated for appetite stimulation in dogs. It is FDA approved and available in 10 ml bottles w/1 ml dosing syringe, 15 ml bottles w/2.5 ml dosing syringe, or 30 ml bottles w/7 ml dosing syringe.
What is Entyce 30 mg/ml Capromorelin Oral Solution for Dogs?
Entyce 30 mg/ml Capromorelin Oral Solution is indicated for appetite stimulation in dogs.
Which animals/pets is Entyce 30 mg/ml Capromorelin Oral Solution for Dogs for?
Dogs
Entyce 30 mg/ml Capromorelin Oral Solution for Dogs uses
-Entyce (capromorelin oral solution) is the ONLY FDA-approved therapeutic that was developed specifically to stimulate appetite in dogs
-Has a targeted mechanism of action that mimics ghrelin (the “hunger hormone”) to trigger the feeling of hunger
-Proven to effectively and safely stimulate appetite in dogs
-Convenient, once-daily oral solution for treating inappetence
What does Entyce 30 mg/ml Capromorelin Oral Solution for Dogs do?
ENTYCE (capromorelin oral solution) is a selective ghrelin receptor agonist that binds to receptors and affects signaling in the hypothalamus to cause appetite stimulation and binds to the growth hormone secretagogue receptor in the pituitary gland to increase growth hormone secretion.
Entyce 30 mg/ml Capromorelin Oral Solution for Dogs side effects
Side Effects may include : Diarrhea, Vomiting, Hypersalivation, Abdominal discomfort, Flatulence, Nausea, Lethargy/depression
CLINICAL PATHOLOGY : Elevated blood urea nitrogen, Elevated phosphorus, Elevated creatinine, Polydipsia
Entyce 30 mg/ml Capromorelin Oral Solution for Dogs ingredients
Capromorelin 30 mg/ml
Entyce 30 mg/ml Capromorelin Oral Solution for Dogs overdose: What to do?
Contact your nearest emergency animal hospital
What to know before using Entyce 30 mg/ml Capromorelin Oral Solution for Dogs
Keep away from children and animals. Contraindications : ENTYCE should not be used in dogs that have a hypersensitivity to capromorelin. Warnings : Not for use in humans. Consult a physician in case of accidental ingestion by humans. For use in dogs only. Precautions: Use with caution in dogs with hepatic dysfunction. ENTYCE is metabolized by CYP3A4 and CYP3A5 enzymes (See Clinical Pharmacology). Use with caution in dogs with renal insufficiency. ENTYCE is excreted approximately 37% in urine and 62% in feces (See Adverse Reactions and Clinical Pharmacology). The safe use of ENTYCE has not been evaluated in dogs used for breeding or pregnant or lactating bitches.
How is Entyce 30 mg/ml Capromorelin Oral Solution for Dogs sold?
30 mg/ml Capromorelin Oral Solution in : 10 ml bottle w/1 ml dosing syringe, 15 ml bottle w/2.5 ml dosing syringe, or 30 ml bottle w/7 ml dosing syringe
Manufacturer
Elanco Animal Health
Overview
Use as directed by your Veterinarian
Dosage and Administration
Administer ENTYCE orally at a dose of 3 mg/kg (1.4 mg/lb) body weight once daily.
To administer ENTYCE, gently shake the bottle, and then withdraw the appropriate amount of solution using the provided syringe. Rinse syringe between treatment doses.
Main Ingredients
Capromorelin 30 mg/ml